Abridge raises $250 million highlighting ‘billable notes’
In this edition of STAT Health Tech: HHS cuts impacting AI regulation at FDA, ambient scribe company Abridge's fundraise, and more.

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday.
Bill, baby, bill: Abridge announces $250 million raise
Abridge announced a $250 million Series D fundraise co-led by investor Elad Gil and IVP with participation from many other notable venture firms. Abridge, which has emerged as one of the leaders amid the boom in companies using technology to streamline clinical documentation, announced today it has over 100 health system customers, including big names like Duke Health, Johns Hopkins, and Mayo Clinic.